N
NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.
Investor insights
Funding rounds participated in
$2.8M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Medical Equipment Manufacturing
Sectors
Medical Equipment Manufacturing
Date founded
2007
Funding rounds raised
Total raised
$2.8M
from investors over 1 rounds
N
NeoChord, Inc. raised $2.8M on June 6, 2021